Meitheal
1 products tracked · names used in filings: Meitheal
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 22 Oct 2025🇺🇸 FDA approval
FDA approves Contepo (fosfomycin disodium): new active ingredient
Meitheal; NDA212271; New active ingredient, Priority review; powder · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Contepo fosfomycin disodium | Approved | 2025-10-22 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.